Dark

ZTS
ZOETIS INC.
stock NYSE

Market Open

Jun 30, 2026 2:24:01 PM EDT

72.26USD-1.345%(-0.99)3,863,846

72.23Bid 72.31Ask 0.08Spread

Pre-market

Jun 30, 2026 9:21:30 AM EDT

73.51USD+0.355%(+0.26)7,326

After-hours

Jun 29, 2026 4:40:30 PM EDT

73.29USD+0.048%(+0.04)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 14, 2022

09:47AM EST Zoetis's Ex-Dividend Date Is Tuesday, Here's What You Need To Know Benzinga

06:03AM EST FDA Approves Zoetis' Solensia To Control Osteoarthritis Pain In Cats Benzinga

03:19AM EST The U.S. Food and Drug Administration approved Zoetis Inc.'s Solensia (frunevetmab injection) to control pain in cats associated with osteoarthritis. RTTNews

Jan 13, 2022

01:37PM EST Zoetis Announces FDA Approval Of Solensia (frunevetmab injection) To Control Osteoarthritis Pain In Cats Benzinga

Jan 5, 2022

11:24AM EST Zoetis Announces FDA Approval of Simparica Trio New Label Indication For Prevention Of Borrelia Burgdorferi Infections In Dogs Benzinga

Dec 20, 2021

04:23PM EST BMO Global Asset Management Announces Annual Reinvested Distributions for BMO PR Newswire

09:53AM EST Citigroup Maintains Neutral on Zoetis, Raises Price Target to $232 Benzinga

Dec 8, 2021

09:54AM EST Price To Earnings Ratio Insights For Zoetis Benzinga

09:21AM EST Zoetis Raises FY22 Dividend By 30%, Announces New Buyback Program Of $3.5B Benzinga

Dec 7, 2021

04:25PM EST Zoetis Reports $3.5B Buyback Benzinga

Dec 2, 2021

12:09PM EST Here's How Much You Would Have Made Owning Zoetis Stock In The Last 5 Years Benzinga

Nov 18, 2021

10:19AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021 Benzinga

09:35AM EST Morgan Stanley Initiates Coverage On Zoetis with Overweight Rating, Announces Price Target of $264 Benzinga

Nov 5, 2021

11:10AM EDT Barclays Maintains Overweight on Zoetis, Raises Price Target to $240 Benzinga

Nov 4, 2021

08:27AM EDT Zoetis Inc. (ZTS) on Thursday reported higher earnings in the third quarter, that beat the consensus estimate. The company also provided full-year earnings outlook, better than the Street view. RTTNews

07:32AM EDT Zoetis Inc. (ZTS) revealed earnings for its third quarter that rose from the same period last year. RTTNews

07:15AM EDT Zoetis Q3 EPS $1.16; Adj EPS $1.25 RTTNews

07:14AM EDT UPDATE: Zoetis Raises FY21 Adj. EPS Guidance From $4.47-$4.55 To $4.62-$4.67 vs $4.55 Estimate, Sales From $7.625B-$7.7B To $7.7B-$7.75B vs $7.7B Est. Benzinga

07:13AM EDT Zoetis Q3 EPS $1.16 Beats $1.10 Estimate, Sales $1.99B Beat $1.93B Estimate; Raises Guidance Benzinga

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Sep 15, 2021

07:10AM EDT Cramer Weighs In On Lennar, Alibaba And More Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 10, 2021

02:42PM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Aug 9, 2021

08:04AM EDT 10 Biggest Price Target Changes For Monday Benzinga

07:37AM EDT Credit Suisse Maintains Outperform on Zoetis, Raises Price Target to $230 Benzinga

Aug 6, 2021

09:32AM EDT Barclays Maintains Overweight on Zoetis, Raises Price Target to $235 Benzinga

Aug 5, 2021

10:21AM EDT While reporting financial results for the second quarter on Thursday, animal health company Zoetis Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2021. RTTNews

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

07:28AM EDT Zoetis Inc. (ZTS) reported earnings for its second quarter that increased from last year. RTTNews

07:15AM EDT Zoetis Q2 EPS $1.07; Adj EPS $1.19 RTTNews

07:03AM EDT Zoetis Raises FY21 Adj. EPS Guidance From $4.42-$4.51 To $4.47-$4.55 vs $4.52 Est., Raises Sales Guidance From $7.5B-$7.625B To $7.625B-$7.7B vs $7.59B Est. Benzinga

07:02AM EDT Zoetis Raises Guidance Benzinga

07:01AM EDT Zoetis Q2 Adj. EPS $1.19 Beats $1.08 Estimate, Sales $1.90B Beat $1.82B Estimate Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 4, 2021

08:59AM EDT Zoetis Earlier Announced The Acquisition Of Jurox; Terms Not Disclosed Benzinga

Aug 3, 2021

10:22AM EDT Price Over Earnings Overview: Zoetis Benzinga

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

Jul 16, 2021

10:15AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021 Benzinga

09:11AM EDT ZTS UPDATE: Raymond James On Zoetis Downgrade: Although Firm Remains Global Leader In Animal Health That Is Well-Positioned For Above-Average Industry Growth, Firm Warns Investors That They Should Resist 'Fetching' Additional Shares At Current Levels Benzinga

05:03AM EDT Raymond James Downgrades Zoetis to Market Perform Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 14, 2021

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

Jul 13, 2021

10:47AM EDT UPDATE: Credit Suisse On Zoetis Outperform Reiteration: Firm Sees Co. 'As The Best Positioned In Animal Health' Given Its Comprehensive, Innovative Portfolio With Encouraging Responses Regarding Simparica Trio Coupled With Upcoming Monoclonal Antibody Benzinga

10:47AM EDT Credit Suisse Reiterates Outperform Rating On Zoetis Benzinga

08:05AM EDT The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data Benzinga

Jul 12, 2021

10:14AM EDT Stocks That Hit 52-Week Highs On Monday Benzinga

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jul 2, 2021

08:30AM EDT Zoetis Donates COVID-19 Vaccines To 'Help Support The Health Of Zoo Animals' Benzinga

07:38AM EDT The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures Benzinga

Jul 1, 2021

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

Jun 30, 2021

07:29AM EDT The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 25, 2021

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

Jun 18, 2021

07:46AM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Jun 17, 2021

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

Jun 16, 2021

08:20AM EDT The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO Benzinga

Jun 15, 2021

08:07AM EDT The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda Benzinga

Jun 11, 2021

08:05AM EDT The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts Benzinga

May 28, 2021

08:54AM EDT Argus Research Maintains Buy on Zoetis, Raises Price Target to $195 Benzinga

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

May 14, 2021

04:56PM EDT 'Fast Money Halftime Report' Picks For May 14 Benzinga

May 12, 2021

10:10AM EDT Citigroup Maintains Neutral on Zoetis, Raises Price Target to $184 Benzinga

May 11, 2021

07:29AM EDT Zoetis Announces Appointment Of Glenn David As Group President And Wetteny Joseph As Executive Vice President And Chief Financial Officer Benzinga

May 7, 2021

08:48AM EDT Raymond James Maintains Outperform on Zoetis, Raises Price Target to $192 Benzinga

May 6, 2021

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

07:32AM EDT While reporting financial results for the first quarter on Thursday, animal health company Zoetis Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2021. RTTNews

07:17AM EDT Zoetis Q1 EPS $1.17; Adj EPS $1.26 RTTNews

07:08AM EDT Zoetis Raises FY21 Guidance: Adj. EPS From $4.36-$4.46 To $4.42-$4.51 vs $4.45 Estimate, Sales From $7.4B-$7.55B To $7.5B-$7.625B vs $7.47B Est. Benzinga

07:08AM EDT Zoetis Q1 Adj. EPS $1.26 Beats $1.03 Estimate, Sales $1.84B Beat $1.73B Estimate Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 19, 2021

10:18AM EDT Analyzing Zoetis's Ex-Dividend Date Benzinga

Mar 8, 2021

01:00PM EST BofA Upgrades Zoetis Stock On Business Potential, Valuation Benzinga

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2021 Benzinga

09:52AM EST Price Over Earnings Overview: Zoetis Benzinga

08:47AM EST Raymond James Upgrades Zoetis to Outperform, Announces $166 Price Target Benzinga

07:36AM EST B of A Securities Upgrades Zoetis to Buy, Announces $180 Price Target Benzinga

Feb 22, 2021

06:01AM EST A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street Benzinga

05:19AM EST Zoetis' Solensia Wins European Nod For Osteoarthritis Pain In Cats Benzinga

Feb 17, 2021

10:08AM EST Price Over Earnings Overview: Zoetis Benzinga

08:57AM EST A Look Into Zoetis's Debt Benzinga

08:36AM EST 10 Biggest Price Target Changes For Wednesday Benzinga

08:02AM EST Credit Suisse Maintains Outperform on Zoetis, Raises Price Target to $203 Benzinga

Feb 16, 2021

10:27AM EST Zoetis shares were trading higher after the company reported better-than-expected Q4 EPS and sales results. The company also issued FY21 EPS and sales results. Benzinga

08:41AM EST Zoetis: Q4 Earnings Insights Benzinga

07:44AM EST Zoetis Inc. (ZTS) announced a profit for fourth quarter that fell from the same period last year. RTTNews

07:43AM EST Animal health company Zoetis Inc. (ZTS) on Tuesday reported net income for the fourth quarter of $359 million or $0.75 per share, down from $384 million or $0.80 per share in the year-ago period. RTTNews

07:31AM EST Zoetis Q4 EPS $0.75; Adj EPS $0.91 RTTNews

07:22AM EST Zoetis Sees FY21 Sales $7.4B-$7.55B Vs. $7.11B Est., EPS $4.36-$4.46 Vs. $4.26 Est. Benzinga

07:19AM EST Zoetis Q4 EPS $0.91 Beats $0.87 Estimate, Sales $1.81B Beat $1.73B Estimate Benzinga

06:49AM EST Earnings Scheduled For February 16, 2021 Benzinga

Feb 15, 2021

10:28AM EST Zoetis Earnings Preview Benzinga

Jan 13, 2021

10:20AM EST Zoetis CEO Says Pandemic Has Accelerated Pet Adoptions, Increased Spending On Pets; Says Ecommerce Revs. Up 70% During Pandemic; Says Growth Of Global Middle Class, Rising Protein Consumption Will Continue To Boost Livestock Business Benzinga

Dec 18, 2020

05:21PM EST BMO Global Asset Management Announces Annual Reinvested Distributions for BMO PR Newswire

Nov 16, 2020

02:44PM EST BMO Global Asset Management Announces Estimated Annual Reinvested Distributions PR Newswire

Nov 13, 2020

09:54AM EST Price Over Earnings Overview: Zoetis Benzinga

08:32AM EST Morgan Stanley Maintains Equal-Weight on Zoetis, Raises Price Target to $174 Benzinga

Nov 12, 2020

08:13AM EST Zoetis Receives European Commission Marketing Authorization for Librela Benzinga

Nov 6, 2020

07:47AM EST The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold Benzinga

Nov 5, 2020

07:34AM EST While reporting financial results for the third quarter on Thursday, animal health company Zoetis Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2020 to reflect strong performance over the past nine months. RTTNews

07:15AM EST Zoetis Q3 Adjusted EPS $1.10; EPS $1.00 RTTNews

07:06AM EST Zoetis Raises FY20 Guidance: Adj. EPS From $3.17-$3.42 To $3.76-$3.81 vs $3.64 Estimate, Sales $5.95B-$6.25B To $6.55B-$6.625B vs $6.43B Est. Benzinga

07:05AM EST Zoetis Q3 Adj. EPS $1.10 Beats $0.91 Estimate, Sales $1.79B Beat $1.63B Estimate Benzinga

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Nov 4, 2020

06:16PM EST Notable Earnings Watchlist For Thursday, Nov. 5, 2020 Before Market Open: MUR, ODP, WRK, REGN, ZTS, BLL, CAH, CIR, CBB, ABC, AGIO, AKBA, CMLS, AZN, HBI, CPRI, CNP, CNHI, CRON, GM, HII, NYT, PPL, MLCO, TEVA, BMY, BABA, AAWW, DUK, AMRN, CI, BDX Benzinga

Nov 2, 2020

08:59AM EST Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23 Benzinga

Sep 21, 2020

09:48AM EDT Benzinga's Top Upgrades, Downgrades For September 21, 2020 Benzinga

05:34AM EDT Atlantic Equities Initiates Coverage On Zoetis with Overweight Rating, Announces Price Target of $191 Benzinga

Sep 4, 2020

04:28PM EDT 'Halftime Report' Share Their Thoughts On Zoetis, General Motors And Trex Benzinga

Aug 20, 2020

08:09AM EDT Morgan Stanley Maintains Equal-Weight on Zoetis, Raises Price Target to $167 Benzinga

Aug 12, 2020

11:28AM EDT Gabelli & Co. Downgrades Zoetis to Hold Benzinga

Aug 10, 2020

01:32PM EDT Truist Securities Maintains Hold on Zoetis, Raises Price Target to $160 Benzinga

08:17AM EDT Citigroup Maintains Neutral on Zoetis, Raises Price Target to $160 Benzinga

Aug 6, 2020

09:18AM EDT Zoetis Raises And Narrows FY20 Guidance: Sees Adj. EPS $3.52 To $3.68 Benzinga

09:14AM EDT Zoetis Earlier Reported Q2 Adj. EPS $0.89 Beats $0.64 Estimate, Sales $1.55B Beat $1.35B Estimate Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

07:54AM EDT Animal health company Zoetis Inc. (ZTS) on Thursday reported net income for the second quarter of $377 million or $0.79 per share, up from $371 million or $0.77 per share in the year-ago period. RTTNews

07:27AM EDT Zoetis Q2 EPS $0.79; Adj EPS $0.89 RTTNews

05:28AM EDT Earnings Scheduled For August 6, 2020 Benzinga

Jul 30, 2020

09:29AM EDT Citigroup Maintains Neutral on Zoetis, Raises Price Target to $146 Benzinga

Jul 20, 2020

11:15AM EDT B of A Securities Maintains Neutral on Zoetis, Raises Price Target to $150 Benzinga

document.getElementById("fm2Mpx").onerror = function(){this.style.display='none';}; .dark-mode .HykGNQ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .HykGNQ{ color: #333333; background-color: white; border: 2px solid #333333; }ZTSZOETIS INC.stock NYSE

ZTS
ZOETIS INC.
stock NYSE